樂心醫療(300562.SZ)第三季度淨利潤預增91.08%-148.71%
格隆匯 9 月 13日丨樂心醫療(300562.SZ)公佈,預計2020年前三季度歸屬於上市公司股東的淨利潤5017.98萬元–5770.67萬元,同比增長100%-130%。其中,2020年第三季度歸屬於上市公司股東的淨利潤2495.58萬元–3248.28萬元,同比增長91.08%-148.71%。
報告期內,公司致力於針對運動健康、慢病管理等領域為廣大客户提供健康IoT與智能健康整體解決方案戰略,行業繼續保持良好的增長態勢。公司緊抓智能可穿戴和醫療健康行業快速發展的機會,充分發揮醫療級消費電子領域的優勢,繼續聚焦戰略大客户,在智能手環、手錶等項目上與新的戰略大客户合作,持續加大創新研發投入,不斷提升核心競爭力,大客户戰略成效顯著。同時加強內部管理,提升投入產出效益,公司業績實現較快增長。
報告期內,公司非經常性損益對淨利潤的影響額預計約為435萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.